116
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Sex Differences in the International Primary Care Airways Group Questionnaire for Screening of Chronic Obstructive Pulmonary Disease: A Retrospective, Cross-Sectional Study

ORCID Icon, ORCID Icon, , , ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1467-1476 | Published online: 22 Jun 2022

References

  • Naberan K, de la Roza C, Lamban M, Gobartt E, Martín A, Miravitlles M. Use of spirometry in the diagnosis and treatment of chronic obstructive pulmonary disease in primary care. Arch Bronconeumol. 2006;42:638–644. doi:10.1157/13095973
  • Price DB, Tinkelman DG, Halbert RJ, et al. Symptom-based questionnaire for identifying COPD in smokers. Respiration. 2006;73:285–295. doi:10.1159/000090142
  • Price DB, Tinkelman DG, Nordyke RJ, Isonaka S, Halbert RJ. Scoring system and clinical application of COPD diagnostic questionnaires. Chest. 2006;129:1531–1539. doi:10.1378/chest.129.6.1531
  • Kida K, Wakabayashi R, Mizuuchi T, Murata A. Screening for suspected chronic obstructive pulmonary disease with an eleven-item pre-interview questionnaire (11-Q). Intern Med. 2006;45:1201–1207. doi:10.2169/internalmedicine.45.1694
  • Martinez FJ, Raczek AE, Selfer FD, et al. Development and initial validation of a self-scored COPD Population Screener Questionnaire (COPD-PS). COPD. 2008;5:85–95. doi:10.1080/15412550801940721
  • Sichletidis L, Spyratos D, Papaioannou M, et al. A combination of the IPAG questionnaire and PiKo-6® flow meter is a valuable screening tool for COPD in the primary care setting. Prim Care Respir J. 2011;20:184–189. doi:10.4104/pcrj.2011.00038
  • Frith P, Crockett A, Beilby J, et al. Simplified COPD screening: validation of the PiKo-6® in primary care. Prim Care Respir J. 2011;20:190–198. doi:10.4104/pcrj.2011.00040
  • Stanley AJ, Hasan I, Crockett AJ, van Schayck OCP, Zwar NA. Validation of the COPD Diagnostic Questionnaire in an Australian general practice cohort: a cross-sectional study. Prim Care Respir J. 2014;23:92–97. doi:10.4104/pcrj.2014.00015
  • Stanley AJ, Hasan I, Crockett AJ, van Schayck OCP, Zwar NA. COPD Diagnostic Questionnaire (CDQ) for selecting at-risk patients for spirometry: a cross-sectional study in Australian general practice. NPJ Prim Care Respir Med. 2014;24:14024. doi:10.1038/npjpcrm.2014.24
  • Spyratos D, Haidich AB, Chloros D, Michalopoulou D, Sichletidis L. Comparison of three screening questionnaires for chronic obstructive pulmonary disease in the primary care. Respiration. 2017;93:83–89. doi:10.1159/000453586
  • Tsukuya G, Samukawa T, Matsumoto K, et al. Comparison of the COPD Population Screener and International Primary Care Airway Group questionnaires in a general Japanese population: the Hisayama study. Int J Chron Obstruct Pulmon Dis. 2016;11:1903–1909. doi:10.2147/COPD.S110429
  • Kotz D, Nelemans P, van Schayck CP, Wesseling GJ. External validation of a COPD diagnostic questionnaire. Eur Respir J. 2008;31:298–303. doi:10.1183/09031936.00074307
  • Kawayama T, Minakata Y, Matsunaga K, et al. Validation of symptom-based COPD questionnaires in Japanese subjects. Respirology. 2008;13:420–426. doi:10.1111/j.1440-1843.2008.01241.x
  • Ntritsos G, Franek J, Belbasis L, et al. Gender-specific estimates of COPD prevalence: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2018;13:1507–1514. doi:10.2147/COPD.S146390
  • Aryal S, Diaz-Guzman E, Mannino DM. Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes. Int J Chron Obstruct Pulmon Dis. 2014;9:1145–1154. doi:10.2147/COPD.S54476
  • Martinez CH, Raparla S, Plauschinat CA, et al. Gender differences in symptoms and care delivery for chronic obstructive pulmonary disease. J Womens Health. 2012;21:1267–1274. doi:10.1089/jwh.2012.3650
  • Agusti A, Calverley PMA, Celli B, et al., The Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010;11:122. doi:10.1186/1465-9921-11-122
  • Gonzalez AV, Suissa S, Ernst P. Gender difference in survival following hospitalisation for COPD. Thorax. 2011;66:38–42. doi:10.1136/thx.2010.141978
  • Celli B, Vestbo J, Jenkins CR, et al. Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience. Am J Respir Crit Care Med. 2011;183:317–322. doi:10.1164/rccm.201004-0665OC
  • de Torres JP, Casanova C, Hernández C, Abreu J, Aguirre-Jaime A, Celli BB. Gender and COPD in patients attending a pulmonary clinic. Chest. 2005;128:2012–2016. doi:10.1378/chest.128.4.2012
  • McClaran SR, Harms CA, Pegelow DF, Dempsey JA. Smaller lungs in women affect exercise hyperpnea. J Appl Physiol. 1998;84(6):1872–1881. doi:10.1152/jappl.1998.84.6.1872
  • Harms CA. Does gender affect pulmonary function and exercise capacity? Respir Physiol Neurobiol. 2006;151(2–3):124–131. doi:10.1016/j.resp.2005.10.010
  • Grouse L, DeWeerdt S, eds. IPAG Diagnosis and Management Handbook. Chronic Airways Diseases: A Guide for Primary Care Physicians. Edgewater: MRC Vision, Inc.; 2005.
  • Takahashi E, Moriyama K, Yamakado M, Ningen Dock Database Group T; The Ningen Dock Database Group. Status of diabetes treatment in Japanese adults: an analysis of the 2009 Japan Society of Ningen Dock database. Intern. Med. 2014;53:1491–1496. doi:10.2169/internalmedicine.53.1876
  • Kubota M, Kobayashi H, Quanjer PH, Omori H, Tatsumi K, Kanazawa M; The Clinical Pulmonary Functions Committee of the Japanese Respiratory Society. Reference values for spirometry, including vital capacity, in Japanese adults calculated with the LMS method and compared with previous values. Respir Investig. 2014;52:242–250. doi:10.1016/j.resinv.2014.03.003
  • Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176:532–555. doi:10.1164/rccm.200703-456SO
  • Sørheim IC, Johannessen A, Gulsvik A, Bakke PS, Silverman EK, DeMeo DL. Gender differences in COPD: are women more susceptible to smoking effects than men? Thorax. 2010;65:480–485. doi:10.1136/thx.2009.122002
  • Prescott E, Bjerg AM, Andersen PK, Lange P, Vestbo J. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J. 1997;10:822–827.
  • Fukuchi Y, Nishimura M, Ichinose M, et al. COPD in Japan: the Nippon COPD Epidemiology study. Respirology. 2004;9:458–465. doi:10.1111/j.1440-1843.2004.00637.x
  • Ogura T, Tejima T, Moritani Y, Matsuzaki Y, Uchimura K, Aoki M; COPD Research Group in Japan Anti-Tuberculosis Association (JATA). The usefulness of COPD questionnaire for screening COPD subjects. J Jpn Respir Soc. 2009;47:971–977.
  • Samukawa T, Matsumoto K, Tsukuya G, et al. Development of a self-scored persistent airflow obstruction screening questionnaire in a general Japanese population: the Hisayama study. Int J Chron Obstruct Pulmon Dis. 2017;12:1469–1481. doi:10.2147/COPD.S130453
  • Tatsumi K, Kasahara Y, Kurosu K, Tanabe N, Takiguchi Y, Kuriyama T; The Respiratory Failure Research Group in Japan. Clinical phenotypes of COPD: results of a Japanese epidemiological survey. Respirology. 2004;9:331–336. doi:10.1111/j.1440-1843.2004.00611.x
  • Miravitlles M, Calle M, Soler-Cataluña JJ. Clinical phenotypes of COPD: identification, definition and implications for guidelines. Arch Bronconeumol. 2012;48:86–98. doi:10.1016/j.arbres.2011.10.007
  • Arimura Y, Yamazaki S, Shirahama T, et al. The accuracy of COPD questionnaires in the general health check-up setting. J Jpn Respir Soc. 2008;46:693–699.